Physician

Ayman H Basali, M.D.

According to 2025 Medicare claims, Ayman Basali, M.D. (NPI: 1861457509) practices pain management, with the plurality of this provider's patient population coming from Wayne, OH. This provider's primary affiliated billing organization is PAIN MANAGEMENT INSTITUTE LLC (NPI: 1992972111; TIN: 26-1753268) and primary practice location at 44691-2340.

Basali's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 323 traditional Medicare patients, billed 10,091 HCPCS/CPT codes, and received $324,397 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 6,177 prescription claims across 566 beneficiaries totaling $473,735 in drug costs, led by Xtampza Er (Oxycodone Myristate). DME data shows 12 claims. Open Payments data shows 43 records totaling $938. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $329,300 to $473,735. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $4,481 to $495.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	431	25,681	$477,972
2016	490	30,172	$540,503
2017	527	31,021	$552,362
2018	481	28,955	$504,862
2019	454	28,633	$502,893
2020	431	26,674	$504,577
2021	443	26,885	$630,946
2022	400	22,115	$524,086
2023	385	14,124	$415,151
2024	323	10,091	$324,397

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	483	5,242	$329,300
2016	488	5,473	$291,810
2017	565	6,232	$376,739
2018	562	6,219	$423,281
2019	594	6,079	$604,555
2020	620	6,682	$496,652
2021	636	6,890	$530,452
2022	620	6,463	$494,865
2023	587	5,931	$490,795
2024	566	6,177	$473,735

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	13	62	$3,008
2016	11	62	$1,541
2017	12	44	$690
2018	12	39	$882
2019	N/R	48	$1,381
2020	N/R	39	$1,180
2021	N/R	31	$876
2022	N/R	27	$1,003
2023	N/R	29	$1,124
2024	N/R	12	$495

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	286	1,250	$93
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	166	344	$68
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	257	4,241	$1
J1885	Injection, ketorolac tromethamine, per 15 mg	174	826	$1
J2250	Injection, midazolam hydrochloride, per 1 mg	244	2,223	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtampza Er	Oxycodone Myristate	369	9,312	$195,555
Buprenorphine	Buprenorphine	461	11,934	$121,454
Belbuca	Buprenorphine Hcl	128	2,940	$47,462
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	1,205	29,190	$19,730
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	496	13,008	$11,356

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4595	Electrical stimulator supplies, 2 lead, per month, (e.g., tens, nmes)	N	N/R	12	$495

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	43	$938	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ayman H. Basali, M.D.?

Tedicare shows public-source Medicare data for Ayman H. Basali, M.D. (NPI 1861457509), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ayman H. Basali, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ayman H. Basali, M.D.?

Ayman H. Basali, M.D. is linked to PAIN MANAGEMENT INSTITUTE LLC (billing NPI 1992972111) in the available physician profile data.

Does Ayman H. Basali, M.D. have Open Payments data?

Ayman H. Basali, M.D. has 43 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.